30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Briggs Morrison

Track

Insider profile

Currently holds positions in Syndax Pharmaceuticals Inc, Arvinas Inc and NextCure Inc

Performance

Overall performance
3.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
15 47% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 197%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Executive Officer, Director Syndax Pharmaceuticals Inc July 1, 2015 -
Independent Director Arvinas Inc June 1, 2018 -
Independent Director NextCure Inc April 1, 2019 -
Executive Vice President - Global Medicines Development AstraZeneca PLC Jan. 1, 2013 - Sept. 15, 2015
Briggs Morrison's trades of Arvinas Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-09 2026-03-06
US Arvinas Inc (ARVN)
B Purchase
89,657 -20.0%
88.01
US$2,395,449 		89,657 -20.0% 88.01 US$2,395,449
2025-09-24 2025-09-22
US Arvinas Inc (ARVN)
B Purchase
67,745 +4.6%
188.71
US$250,459 		67,745 +4.6% 188.71 US$250,459
2023-08-10 2023-08-09
S Sale
30,186 +22.6%
313.42
US$4,183,508 		30,186 +22.6% 313.42 US$4,183,508
2023-08-09 2023-08-09
PrS Proposed sale
52,855
18.25
US$964,604 		52,855 18.25 US$964,604
2023-07-11 2023-07-10
S Sale
52,855 -74.8%
20.40
US$1,078,068 		52,855 -74.8% 20.40 US$1,078,068
2023-07-10 2023-07-10
PrS Proposed sale
52,855
20.30
US$1,072,956 		52,855 20.30 US$1,072,956
2023-06-09 2023-06-09
PrS Proposed sale
52,855
21.32
US$1,126,869 		52,855 21.32 US$1,126,869
2023-06-09 2023-06-09
S Sale
28,273 -61.3%
21.18
US$598,797 		28,273 -61.3% 21.18 US$598,797
2023-06-09 2023-06-09
S Sale
24,582 -34.8%
21.18
US$520,625 		24,582 -34.8% 21.18 US$520,625
2023-05-10 2023-05-09
S Sale
52,855 -74.8%
21.41
US$1,131,478 		52,855 -74.8% 21.41 US$1,131,478
2023-05-09 2023-05-09
PrS Proposed sale
52,855
20.29
US$1,072,428 		52,855 20.29 US$1,072,428
2023-04-12 2023-04-10
S Sale
52,855 -74.8%
19.53
US$1,032,237 		52,855 -74.8% 19.53 US$1,032,237
2023-03-14 2023-03-13
PlS Planned sale
52,854 -74.8%
22.53
US$1,190,674 		52,854 -74.8% 22.53 US$1,190,674
2023-02-08 2023-02-06
PlS Planned sale
52,854 -74.8%
26.83
US$1,417,909 		52,854 -74.8% 26.83 US$1,417,909
2022-09-21 2022-09-20
PlS Planned sale
59,649 -77.0%
23.25
US$1,387,012 		59,649 -77.0% 23.25 US$1,387,012
2022-09-21 2022-09-19
PlS Planned sale
114,339 -86.5%
23.03
US$2,633,044 		114,339 -86.5% 23.03 US$2,633,044
2022-09-16 2022-09-16
PlS Planned sale
53,034 -74.8%
23.22
US$1,231,423 		53,034 -74.8% 23.22 US$1,231,423
2022-09-16 2022-09-16
PlS Planned sale
71,966 -80.1%
23.22
US$1,671,015 		71,966 -80.1% 23.22 US$1,671,015
2022-09-16 2022-09-15
PlS Planned sale
66,775 -78.9%
24.20
US$1,616,035 		66,775 -78.9% 24.20 US$1,616,035
2022-09-16 2022-09-14
PlS Planned sale
87,645 -83.1%
23.80
US$2,085,855 		87,645 -83.1% 23.80 US$2,085,855
2022-07-05 2022-07-01
PlS Planned sale
62,292 -77.7%
19.00
US$1,183,430 		62,292 -77.7% 19.00 US$1,183,430
2022-04-18 2022-04-14
US Arvinas Inc (ARVN)
PlS Planned sale
10,754 -35.0%
67.03
US$720,888 		10,754 -35.0% 67.03 US$720,888
2022-04-18 2022-04-14
US Arvinas Inc (ARVN)
PlS Planned sale
7,104 -18.8%
66.07
US$469,356 		7,104 -18.8% 66.07 US$469,356
2022-04-18 2022-04-14
US Arvinas Inc (ARVN)
PlS Planned sale
3,102 -7.6%
65.24
US$202,372 		3,102 -7.6% 65.24 US$202,372
2022-04-05 2022-04-04
PlS Planned sale
3,128 -14.9%
18.29
US$57,220 		3,128 -14.9% 18.29 US$57,220
2022-04-05 2022-04-01
PlS Planned sale
70,545 -79.8%
17.46
US$1,231,568 		70,545 -79.8% 17.46 US$1,231,568
2022-04-05 2022-04-01
PlS Planned sale
24,500 -57.9%
17.44
US$427,314 		24,500 -57.9% 17.44 US$427,314
2022-04-05 2022-04-01
PlS Planned sale
6,000 -12.4%
17.44
US$104,633 		6,000 -12.4% 17.44 US$104,633
2022-01-19 2022-01-14
US Arvinas Inc (ARVN)
PlS Planned sale
2,108 -7.8%
67.69
US$142,696 		2,108 -7.8% 67.69 US$142,696
2022-01-19 2022-01-14
US Arvinas Inc (ARVN)
PlS Planned sale
5,100 -16.0%
67.28
US$343,144 		5,100 -16.0% 67.28 US$343,144
2022-01-19 2022-01-14
US Arvinas Inc (ARVN)
PlS Planned sale
3,833 -10.7%
65.24
US$250,071 		3,833 -10.7% 65.24 US$250,071
2022-01-19 2022-01-14
US Arvinas Inc (ARVN)
PlS Planned sale
9,919 -21.7%
64.33
US$638,109 		9,919 -21.7% 64.33 US$638,109
2021-12-20 2021-12-17
PlS Planned sale
35,156 -42.1%
20.00
US$703,120 		35,156 -42.1% 20.00 US$703,120
2021-02-17 2021-02-17
B Purchase
4,761 +inf%
21.00
US$99,981 		4,761 +inf% 21.00 US$99,981
2021-02-10 2021-02-08
PlS Planned sale
35,156 -42.1%
20.55
US$722,403 		35,156 -42.1% 20.55 US$722,403
2020-11-12 2020-11-10
S Sale
17,466 -27.3%
20.06
US$350,312 		17,466 -27.3% 20.06 US$350,312
2020-11-12 2020-11-09
S Sale
62,938 -57.5%
20.04
US$1,261,265 		62,938 -57.5% 20.04 US$1,261,265
2020-06-25 2020-06-23
B Purchase
4,800 +inf%
20.00
US$96,000 		4,800 +inf% 20.00 US$96,000
2020-03-25 2020-03-24
US Arvinas Inc (ARVN)
B Purchase
2,500 +9.3%
38.18
US$95,450 		2,500 +9.3% 38.18 US$95,450
2020-02-05 2020-02-04
B Purchase
12,500 +39.8%
8.00
US$100,000 		12,500 +39.8% 8.00 US$100,000
2019-10-11 2019-10-10
B Purchase
11,000 +53.9%
5.40
US$59,400 		11,000 +53.9% 5.40 US$59,400
2019-05-13 2019-05-13
B Purchase
7,200 +54.5%
7.29
US$52,517 		7,200 +54.5% 7.29 US$52,517
2019-05-13 2019-05-09
B Purchase
13,200 +inf%
7.56
US$99,726 		13,200 +inf% 7.56 US$99,726